Form 4: Provectus Biopharmaceuticals CEO Converts Promissory Note to Preferred Stock

CEO Edward Pershing converted an 8% unsecured convertible promissory note into Series D-1 Convertible Preferred Stock on April 25, 2024.

Summary

• On April 25, 2024, Edward Pershing, CEO of Provectus Biopharmaceuticals, converted an 8% unsecured convertible promissory note into 37,752 shares of Series D-1 Convertible Preferred Stock.
• The conversion occurred at a price of $2.862 per share.
• This conversion was related to the Issuer's 2022 Financing.
• Each share of Series D-1 Preferred Stock is convertible into 10 shares of common stock.
• The Series D-1 Convertible Preferred Stock will automatically convert into Common Stock on June 20, 2026, unless earlier converted.
• Following the transaction, Pershing directly owns 1,178,704 shares of common stock and 1,735,000 shares of Series D-1 Convertible Preferred Stock.

Sentiment

Score: 6

Explanation: The document is a standard SEC filing detailing a routine conversion of debt to equity. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information about insider transactions.

Positives

• The conversion of the promissory note simplifies the company's capital structure.

Future Outlook

The Series D-1 Convertible Preferred Stock will automatically convert into Common Stock on June 20, 2026, unless earlier converted into Common Stock in accordance with the terms of the Certificate of Designation for the Series D-1 Convertible Preferred Stock.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, such as the CEO, and their holdings in the company's securities. This allows investors to track changes in ownership and potential alignment of interests between management and shareholders.

Stakeholder Impact

• The conversion of the promissory note into preferred stock could potentially impact shareholders by increasing the number of shares outstanding upon conversion to common stock.

Key Dates